Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to MaxLinear, Inc. (Nasdaq: MXL) SEC filings, offering a structured view of the company’s regulatory disclosures as a U.S. public issuer. MaxLinear operates in the semiconductor and related device manufacturing industry, supplying RF, analog, digital and mixed-signal integrated circuits for connectivity, infrastructure, and industrial and multi-market applications.
Through its filings with the U.S. Securities and Exchange Commission, MaxLinear reports financial results, material events, and risk factors. Current reports on Form 8‑K have disclosed unaudited quarterly financial results, including net revenue, margins, operating expenses, and earnings measures, as well as the authorization of a share repurchase program that allows the company to buy back a specified amount of its common stock over a multi-year period. These 8‑K filings often incorporate related press releases by reference.
Investors can use this filings page to locate MaxLinear’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which typically contain detailed discussions of the company’s business, segment information, risk factors, management’s discussion and analysis, and notes to the financial statements. The risk factor sections elaborate on topics highlighted in press releases, such as competition in the semiconductor industry, market cyclicality, trade and tariff issues, geopolitical conditions, customer demand variability, legal proceedings, and technology and cybersecurity considerations.
In addition to periodic reports, users can review Forms 8‑K for announcements about financial results, share repurchase authorizations, and other significant events. Where applicable, insider transaction reports on Form 4 and proxy statements on Schedule 14A can provide further insight into executive and director share ownership, equity awards, and governance matters. Stock Titan’s interface is designed to surface these filings as they are made available through EDGAR and to pair them with AI-powered summaries that explain key points, highlight important changes, and help readers interpret complex sections of lengthy documents such as 10‑K and 10‑Q reports.
MXL reporting person Theodore Tewksbury filed a Form 144 indicating an intended sale of 3,935 shares of Common Stock, designated as Restricted Stock, with an execution date listed as 05/01/2026. The filing also reports 2,790 shares sold during the past three months for $219,475.35.
MAXLINEAR, INC Corporate Controller & PAO Connie H. Kwong reported an open-market sale of 4,118 shares of Common Stock at $58.00 per share on April 29, 2026. Following this sale, she directly holds 48,947 shares of MaxLinear common stock.
Morgan Stanley Smith Barney LLC Executive Financial Services filed a Form 144 notice related to proposed sales of Common Stock for filer activities on 04/29/2026. The filing lists multiple blocks of restricted stock grants with stated share counts and shows a sale of 15,050 shares on 04/27/2026 for $771,948.29.
MaxLinear, Inc. executive Connie H. Kwong, the Corporate Controller & PAO, reported an open-market sale of 15,050 shares of Common Stock. The weighted average sale price was $51.2922 per share, and she now directly holds 53,065 shares following this transaction.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice of proposed sales of Common Stock. The filing lists multiple blocks of restricted stock, performance shares and Employee Stock Purchase Plan shares with specific grant dates and share counts (examples: 227, 1,430, 2,621), dated between 02/20/2021 and 02/03/2023.
MaxLinear reported stronger results for the three months ended March 31, 2026, with net revenue of $137.2 million, up from $95.9 million a year earlier, driven mainly by infrastructure and broadband demand.
The company still posted a net loss of $45.1 million, slightly better than the $49.7 million loss in 2025, with basic and diluted net loss per share of $0.52 versus $0.58. A higher income tax provision of $26.5 million weighed on results.
Operating cash flow was negative $8.9 million, an improvement from negative $11.4 million. Cash, cash equivalents and restricted cash were $89.9 million and long-term debt remained at $125.0 million, with an undrawn revolving facility and significant inventory purchase commitments supporting future demand.
MaxLinear, Inc. reported strong first quarter 2026 results and amended its senior secured revolving credit facility. Net revenue was $137.2 million, up 1% sequentially and 43% year over year, with infrastructure revenue up 136% year over year and now the largest end market.
On a GAAP basis, the company posted a net loss of $45.1 million (diluted loss per share of $0.52), while non-GAAP net income was $19.4 million with non-GAAP diluted earnings per share of $0.22. Non-GAAP operating margin was 16% of net revenue.
For second quarter 2026, MaxLinear expects net revenue of $160 million to $170 million, with GAAP gross margin of 56.0%–59.0% and non-GAAP gross margin of 58.0%–61.0%. The company also expects GAAP operating expenses of $91 million to $97 million and non-GAAP operating expenses of $61 million to $66 million.
Separately, MaxLinear entered into a Second Amendment to its Credit Agreement, extending the Revolving Facility maturity from June 23, 2026 to March 23, 2028 and increasing total revolving commitments by $30 million to $130 million. As of the amendment closing, the Revolving Facility was undrawn. The amendment adds covenants requiring a total net leverage ratio not greater than 3.50 to 1.00 and minimum liquidity of $80 million, tested quarterly.